Overview

Randomized，Controlled and Open-label Study of Buspirone add-on Treatment in Patients With Major Depression Disorder

Status:
Unknown status

Trial end date:
2015-12-01

Target enrollment:

Participant gender:

Summary

This is a Multicenter, open lable, parallel randomized controlled clinical trial. This study aimed to evaluate the treatment onset time, efficacy and safety in patients with major depressive disorders , accompanying anxiety receiving Buspirone and Paroxetine.

Phase:

Phase 4

Details

Lead Sponsor:

Si Tianmei

Treatments:

Buspirone
Paroxetine